Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Department of Justice
McKinsey
Fuji
McKesson
Covington
US Army
Daiichi Sankyo
Cantor Fitzgerald

Generated: May 25, 2018

DrugPatentWatch Database Preview

Atropine; pralidoxime chloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for atropine; pralidoxime chloride and what is the scope of atropine; pralidoxime chloride patent protection?

Atropine; pralidoxime chloride
is the generic ingredient in two branded drugs marketed by Us Army and Meridian Medcl, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for atropine; pralidoxime chloride. One supplier is listed for this compound.
Summary for atropine; pralidoxime chloride

US Patents and Regulatory Information for atropine; pralidoxime chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army ATNAA atropine; pralidoxime chloride INJECTABLE;INTRAMUSCULAR 021175-001 Jan 17, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Meridian Medcl DUODOTE atropine; pralidoxime chloride INJECTABLE;INTRAMUSCULAR 021983-001 Sep 28, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Teva
Deloitte
Federal Trade Commission
McKesson
Covington
QuintilesIMS
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.